ACHC Quote, Financials, Valuation and Earnings

HCA Healthcare, Inc. has a net margin of 4.5% compared to Acadia Healthcare Co., Inc.'s net margin of 11.09%. Acadia Healthcare Co., Inc.'s return on equity of 3.71% beat HCA Healthcare, Inc.'s return on equity of 3428.29%.

Acadia Healthcare Co., Inc. has a consensus price target of $19.07, signalling upside risk potential of 41.9%. On the other hand HCA Healthcare, Inc. has an analysts' consensus of $521.62 which suggests that it could grow by 6.19%. Given that Acadia Healthcare Co., Inc. has higher upside potential than HCA Healthcare, Inc., analysts believe Acadia Healthcare Co., Inc. is more attractive than HCA Healthcare, Inc..

Acadia Healthcare Co., Inc. has a beta of 0.882, which suggesting that the stock is 11.786% less volatile than S&P 500. In comparison HCA Healthcare, Inc. has a beta of 1.362, suggesting its more volatile than the S&P 500 by 36.191%.

Acadia Healthcare Co., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. HCA Healthcare, Inc. offers a yield of 0.59% to investors and pays a quarterly dividend of $0.72 per share. Acadia Healthcare Co., Inc. pays -- of its earnings as a dividend. HCA Healthcare, Inc. pays out 10.17% of its earnings as a dividend. HCA Healthcare, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Acadia Healthcare Co., Inc. quarterly revenues are $851.6M, which are smaller than HCA Healthcare, Inc. quarterly revenues of $19.5B. Acadia Healthcare Co., Inc.'s net income of $38.3M is lower than HCA Healthcare, Inc.'s net income of $2.2B. Notably, Acadia Healthcare Co., Inc.'s price-to-earnings ratio is 11.40x while HCA Healthcare, Inc.'s PE ratio is 17.31x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Acadia Healthcare Co., Inc. is 0.38x versus 1.56x for HCA Healthcare, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Nutex Health, Inc. has a net margin of 4.5% compared to Acadia Healthcare Co., Inc.'s net margin of 36.15%. Acadia Healthcare Co., Inc.'s return on equity of 3.71% beat Nutex Health, Inc.'s return on equity of 97.36%.

Acadia Healthcare Co., Inc. has a consensus price target of $19.07, signalling upside risk potential of 41.9%. On the other hand Nutex Health, Inc. has an analysts' consensus of $250.00 which suggests that it could grow by 66.89%. Given that Nutex Health, Inc. has higher upside potential than Acadia Healthcare Co., Inc., analysts believe Nutex Health, Inc. is more attractive than Acadia Healthcare Co., Inc..

Acadia Healthcare Co., Inc. has a beta of 0.882, which suggesting that the stock is 11.786% less volatile than S&P 500. In comparison Nutex Health, Inc. has a beta of -0.082, suggesting its less volatile than the S&P 500 by 108.17%.

Acadia Healthcare Co., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutex Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Acadia Healthcare Co., Inc. pays -- of its earnings as a dividend. Nutex Health, Inc. pays out -- of its earnings as a dividend.

Acadia Healthcare Co., Inc. quarterly revenues are $851.6M, which are larger than Nutex Health, Inc. quarterly revenues of $267.8M. Acadia Healthcare Co., Inc.'s net income of $38.3M is lower than Nutex Health, Inc.'s net income of $96.8M. Notably, Acadia Healthcare Co., Inc.'s price-to-earnings ratio is 11.40x while Nutex Health, Inc.'s PE ratio is 8.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Acadia Healthcare Co., Inc. is 0.38x versus 0.94x for Nutex Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Tenet Healthcare Corp. has a net margin of 4.5% compared to Acadia Healthcare Co., Inc.'s net margin of 10.95%. Acadia Healthcare Co., Inc.'s return on equity of 3.71% beat Tenet Healthcare Corp.'s return on equity of 27.14%.

Acadia Healthcare Co., Inc. has a consensus price target of $19.07, signalling upside risk potential of 41.9%. On the other hand Tenet Healthcare Corp. has an analysts' consensus of $237.67 which suggests that it could grow by 25.37%. Given that Acadia Healthcare Co., Inc. has higher upside potential than Tenet Healthcare Corp., analysts believe Acadia Healthcare Co., Inc. is more attractive than Tenet Healthcare Corp..

Acadia Healthcare Co., Inc. has a beta of 0.882, which suggesting that the stock is 11.786% less volatile than S&P 500. In comparison Tenet Healthcare Corp. has a beta of 1.409, suggesting its more volatile than the S&P 500 by 40.933%.

Acadia Healthcare Co., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tenet Healthcare Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Acadia Healthcare Co., Inc. pays -- of its earnings as a dividend. Tenet Healthcare Corp. pays out -- of its earnings as a dividend.

Acadia Healthcare Co., Inc. quarterly revenues are $851.6M, which are smaller than Tenet Healthcare Corp. quarterly revenues of $5.3B. Acadia Healthcare Co., Inc.'s net income of $38.3M is lower than Tenet Healthcare Corp.'s net income of $579M. Notably, Acadia Healthcare Co., Inc.'s price-to-earnings ratio is 11.40x while Tenet Healthcare Corp.'s PE ratio is 13.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Acadia Healthcare Co., Inc. is 0.38x versus 0.84x for Tenet Healthcare Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Universal Health Services, Inc. has a net margin of 4.5% compared to Acadia Healthcare Co., Inc.'s net margin of 8.43%. Acadia Healthcare Co., Inc.'s return on equity of 3.71% beat Universal Health Services, Inc.'s return on equity of 20.13%.

Acadia Healthcare Co., Inc. has a consensus price target of $19.07, signalling upside risk potential of 41.9%. On the other hand Universal Health Services, Inc. has an analysts' consensus of $250.35 which suggests that it could grow by 23.31%. Given that Acadia Healthcare Co., Inc. has higher upside potential than Universal Health Services, Inc., analysts believe Acadia Healthcare Co., Inc. is more attractive than Universal Health Services, Inc..

Acadia Healthcare Co., Inc. has a beta of 0.882, which suggesting that the stock is 11.786% less volatile than S&P 500. In comparison Universal Health Services, Inc. has a beta of 1.282, suggesting its more volatile than the S&P 500 by 28.162%.

Acadia Healthcare Co., Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Universal Health Services, Inc. offers a yield of 0.39% to investors and pays a quarterly dividend of $0.20 per share. Acadia Healthcare Co., Inc. pays -- of its earnings as a dividend. Universal Health Services, Inc. pays out 4.76% of its earnings as a dividend. Universal Health Services, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Acadia Healthcare Co., Inc. quarterly revenues are $851.6M, which are smaller than Universal Health Services, Inc. quarterly revenues of $4.5B. Acadia Healthcare Co., Inc.'s net income of $38.3M is lower than Universal Health Services, Inc.'s net income of $379.1M. Notably, Acadia Healthcare Co., Inc.'s price-to-earnings ratio is 11.40x while Universal Health Services, Inc.'s PE ratio is 9.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Acadia Healthcare Co., Inc. is 0.38x versus 0.78x for Universal Health Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.